Background: Urinary tract infections are found to be commonest bacterial infections across the globe. Various studies have demonstrated high prevalence rate of UTIs in Pakistan. Multiple broad spectrum antibiotics are being used for the treatment of UTI but the resistance by the pathogen against these drugs is increasing worldwide. As the resistance in the organisms is increasing day by day, and it is now hall mark and matter of concern for clinicians to treat uropathogenic E. coli, so there is a pertinent need to explore new sensitive antibiotics or alternative options to manage the disease. Farooq et al.; JPRI, 30(3): 1-7, 2019; Article no.JPRI.51896 2 Aims: To determine the pathogen burden and susceptibility pattern of ceftolozane/tazobactam against MDR E. coli isolates from clinical specimens of urinary tract infections in Karachi. Study Design: It was an in-vitro clinical study. Study Settings: The study was conducted in department of Pharmacology, Baqai Medical University and isolates were collected from Microbiology laboratory of Karachi. Methodology: On the basis of identification methods, one hundred and fifty (150) strains of E. coli were isolated from 650 specimen of urine. Clinical isolates were identified by standard and specific microbiological methods. The antibiotic susceptibility pattern was determined by Kirby Bauer Disc diffusion method. Samples were processed as per procedures defined by Clinical and Laboratory Standards Institute (CLSI) guidelines 2018. Results: Out of 150 isolates of E. coli, 95 (63.3%) were MDR E. coli. majority of the cases were obtained from age group 61-80 year (32.6%). Highest sensitivity was seen by ceftolozane/tazobactam (96%) followed by ceftriaxone (88%). Least sensitivity was observed with Imipenem (13.70%). However increased trend of resistance was seen among all empirical used drugs.
INTRODUCTION
Urinary tract infections (UTI) are the most common bacterial infections encountered in hospitals worldwide [1, 2] . After gastrointestinal and respiratory tract infections in developing countries UTI rank at third position [3] . The major etiologic agent of community acquired (80-90%) as well as nosocomial acquired uropathogenic infections (30-50%) is E. coli [4] .
Studies conducted in different regions of Pakistan have shown high prevalence rate of UTI [5, 6] . Despite UTI is curable but due to multidrug resistant strains, treatment failure and complications are major cause of morbidity and mortality in hospitals. According to Muoneke V et. al. about 150 million people are reported with UTI each year, it is estimated that in united states alone approximately 100,000 patients with UTI are admitted in hospitals per year [7] . If it is diagnosed earlier and managed properly UTI rarely leads to complications, but if it remained undiagnosed the organism may reach to kidneys and will lead to serious consequences such as permanent kidney damage (pyelonephritis), urethral stricture from recurrent urethritis and sepsis a life threatening infection [8] .
UTI may be reported at any stage of life, particularly young and healthy females are more prone to develop UTI. This may be due to anatomical variation, hormonal changes, use of contraceptive pills, longtime catheterization and decreased frequency of urination during pregnancy [9] . Multiple broad spectrum antibiotics are being used for the treatment of UTI but the resistance by the pathogen against these drugs is increasing worldwide [10, 11] .
Injudicious and irrational use of empirical antibiotics and lack of surveillance program regarding antibiotics is major cause of emergence of resistance [11] .
To the best of our knowledge there is no current data available in Pakistan for the use of 5 th generation Cephalosporin antibiotic in infections. As the resistance in the organisms is increasing day by day, and it is now hall mark and matter of concern for clinicians to treat uropathogenic E. coli, so there is a pertinent need to explore new sensitive antibiotics or alternative options to manage the disease. The aim of the study is to determine the prevalence of E. coli in population of Karachi and to evaluate the sensitivity of ceftolozane/tazobactam (C/T) a novel "5 th generation Cephalosporin" antibiotic against E. coli.
MATERIALS AND METHODS
It was a preclinical, experimental in-vitro study, conducted from January 2019 to June 2019 at Baqai Medical University Karachi. Urine Samples were collected from in-door and out-door patients using non probability technique. Total 1700 suspected UTI patients from first day of life to more than 80 years of age of either sexes were included in this study. Patients were educated regarding the aims of the study by an informed consent form. After their agreement as a participant in study detailed history was recorded on a questionnaire. The clean catch midstream urine samples were collected from participants into a wide mouthed sterile container and were sent to Microbiology Lab for culture and sensitivity. All the samples were processed as per microbiological procedures CLSI Guideline 2018. Urine was inoculated on CLED (cysteinelactose and electrolyte-deficient) agar. CLED agar is a differential culture medium for isolating and enumerating bacteria in urine from the suspected cases of urinary tract infections. Urine was mixed by rotating the container. With the help of sterile calibrated wire loop, urine was inoculated on MacConkey's agar and the plate was incubated aerobically at 35-37ºC overnight, then growth of organism was checked on plate, colony count greater than 100000/ml signified the bacterial growth.
Antibiotic Sensitivity Test
The antibiotic sensitivity was performed for confirmed pathogenic E. coli by the standard Kirby Bauer's disc diffusion method and the results were interpreted by the Clinical and Laboratory Standards Institute (CLSI, 2018). Antibiotic discs with different concentrations such as gentamycin (10 ug), amoxicillin (30 ug), ciprofloxacin (5 ug), cotrimaxazole (30 ug), ceftriaxone (30 ug), imipenem 10 ug), moxifloxacin (10ug), C/T (30/10 ug) and cefaclor (30 ug) were tested. Before determination of the results, plates were incubated for 16-24 h at 35ºC. The antibiotics were concluded either sensitive or resistant after the measurement of zones of growth inhibition around each antibiotic disc, the procedure were carried out in accordance to CLSI guidelines (2018).
Statistical Analysis
Data was analyzed by using Statistical Package for Social Sciences (SPSS) version 21. Descriptive analysis for numerical variables were mentioned as Mean with standard deviation. Frequencies and percentages were calculated for categorical variables. Gender, age group and specimen distribution were mentioned in terms of frequencies and percentages. Chi square test was applied to scrutinize the association between sensitivity and resistance of drugs. Pvalue < 0.05% was considered as statistically significant.
RESULTS
On the basis of identification methods, one hundred and fifty (150) strains of E. coli were isolated from 650 specimen of urine. Out of which 95 (63.3%) strains were MDR E. coli and 55 (36.6%) were non MDR E. coli.
MDR E. coli were predominant in females 55 (57.8%) as compared to males, 40 (42.1%) as shown in Table 1 . The mean age of study participants was 54 years with the standard deviation of 20. Majority of the MDR E. coli cases were reported from age group 61-80 years that was 31 (32.6%) as shown in Table 2 . MDR E. coli showed increased resistance to almost commonly used antibiotics. Highest resistance was observed with imipenem (86.3%) followed by amoxicillin (85.20%), gentamycin is (80%), cotrimaxazole (72%), ciprofloxacin (65%), cefaclor(61.0%), moxifloxacin (30%), coceftriaxone (12%) and least resistance was observed against C/T that was 4% . The resistance pattern against antibiotics is shown in Fig. 1. 
DISCUSSION
UTI is a common clinical condition encountered in both the community and health care associated settings. Dromigny et al. reported that among all the causative agents of UTI, E. coli is responsible for about 77-90% of the cases and it is found that the presence of E. coli in gut is a primary source of UTI [12, 13] . In our study the prevalence of E. coli was found to be 23%. However in multiple studies conducted in different regions of Pakistan has shown marked prevalence of E. coli. In a study conducted in Kohat and Gilgat the prevalence was found to be 41% and 47.7% respectively [14, 15] . Even though this trend is not only prevalent in Pakistan but it has shown high frequency rate around the globe. Studies in Nepal, Kashmir, South India, Uganda has shown a marked increase in frequency of UTIs due to E. coli [16, 17, 18, 19] . In this study, out of n=95 (63.3%) MDR strains of E. coli, females were more frequently affected 55 (57.8%), as compared to males 40 (42.1%). These finding are parallel to the studies conducted in Gilgat, Nepal and South India [20, 21, 22] . It is suggested that female patients in age group 41-60y, suffer from post-menopausal changes such as estrogen loss, thinning of epithelium and decrease in vaginal flora that may be a cause of high incidence of UTI particularly in this age group [23, 24] , we in our study also found the high prevalence of UTI in elderly females. With a marked variation MDR E. coli to a certain level was found to have sensitivity to almost all the tested antibiotics , the highest sensitivity (96%) was associated with ceftolozane/ tazobactam followed by ceftriaxone(86%), along with that resistance pattern was shown to be highly significant to most commonly used drugs such as imipenem (86.30%) amoxicillin (85.20%), gentamycin (80%), cotrimoxazole (72%), ciprofloxacin (65%), cefaclor (61.10%) and moxifloxacin (30%).
A study published in Spain showed that gentamicin was thought to be first-line drug in treatment of UTIs, but the resistance to gentamycin was reported [25] and results are in accordance to our study. Findings of our study showed high resistance to beta lactam antibiotics such as amoxicillin, cotrimaxaxole, imipenem, and cefaclor, this trend was escalating day by day in our country and also around the globe [26, 27, 28, 29] .
Higher resistance in MDR E. coli against penicillin and cephalosporins indicates that these may have been misused in health care settings. Quinolones, especially ciprofloxacin have been used for E. coli infections in recent past. In the present study however E. coli were highly resistant to ciprofloxacin (65%) Ullah. A. et al reported the same in Kohat [30] .
The increasing frequency of cross-resistance between beta-lactamases and fluoroquinolones has become a major concern globally [31]. The Study for Monitoring Antimicrobial Resistance Trends (SMART) has reported that fluoroquinolones may no longer be effective as first-line therapy for UTI in hospitalized patients [32] . Ceftolozane/Tazobactam was observed as highly sensitive (96%) drug for MDR E. coli in our study. it is a novel 5 th generation cephalosporin with well-established beta lactamase inhibitors and effective against MDR strains as well as also effective for ESBL E. coli. Phase II and III trials have shown high efficacy and good tolerability in complicated UTI when compared with standard therapy [33] . Clinical trial was conducted which showed higher efficacy when compared to levofloxacin [34] . As we are running out for the antibiotics for the treatment of Uropathogenic E. coli so the therapeutic use of C/T should be reserved only for severe and life threatening infections.
CONCLUSION
UTI due to MDR E. coli may be difficult to treat because of high resistance to commonly used empirical antibiotics. C/T is an appropriate antibiotic to treat UTIs caused by MDR E. coli. Continuous surveillance of multidrug resistant organisms and antimicrobial stewardship needed in order to prevent treatment failure and reduce selective pressure. These findings will help in choosing more suitable treatment options for UTI patients in this region of Pakistan.
LIMITATIONS
The study was confined to one setup only and with that we were just able to encounter the population that visited our OPD.
SUGGESTIONS
The same kind of study should be conducted with collaboration of multiple setups of Karachi to identify the invading organism in large sample size and to validate the effective treatment options for resistant organisms.
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